Interrogating open issues in cancer precision medicine with patient-derived xenografts. - Wikidata - awgldk - TriplyDB

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

http://www.wikidata.org/entity/Q39095733

about

Current status and perspectives of patient-derived xenograft models in cancer research.Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.Mouse models of metastasis: progress and prospects.Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology.Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.Characterization of ascites-derived tumor cells from an endometrial cancer patient.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer.A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.Trial watch: Immune checkpoint blockers for cancer therapy.Current status of proteomics of soft tissue sarcomas.Precision medicine needs pioneering clinical bioinformaticians.Natural Agents-Mediated Targeting of Histone Deacetylases.Pancreatic cancer heterogeneity and response to Mek inhibition.Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.Interrogating open issues in cancer medicine with patient-derived xenografts.Preclinical mouse solid tumour models: status quo, challenges and perspectives.Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.Use of patient-derived xenograft mouse models in cancer research and treatment.Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.Addressing the challenges of applying precision oncology.Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data Modeling Endometrial Cancer: Past, Present, and Future

P2860

Q33667686-F7854AE0-89F7-405E-9EFA-313472723FC8 Q38689944-1CF82766-39E8-4803-ACD2-7CB0E5FC4306 Q41664785-633786A0-7506-4BEC-A925-AC377EB99945 Q44236009-17127FBB-2F28-452F-9576-00B5544C061B Q46142258-D76946C1-69F9-4602-AD65-4D6F5EE32107 Q47123308-BBFC01CA-9821-46FF-A654-C1DC1BCD6A15 Q47133741-3A9CE9CC-3170-4881-A9A4-483E8511029E Q47137308-3A2FDDB4-FD4C-4F37-B07B-BBC7255AE531 Q47145975-31198BA5-68E0-4E6C-BA19-927E2E0F3F51 Q47160287-6EF6E5E6-A5F9-4E51-835D-F1BE94A7EA29 Q47203432-AD180F96-A057-4CB7-BC54-2AE317497F5B Q47204651-2E744AD5-4DE6-4351-9347-6CE97EB0D3A4 Q47281042-C197510A-EFAE-4840-A1D9-29DAB6C43F0E Q47285585-71989843-E2B8-44B6-A5D7-D14C392D0D39 Q47307094-A95607BB-0348-416D-A5B8-6875AE66BC85 Q47393365-0CE148B8-FF4E-429B-AA49-E983803E4432 Q47640603-D69BF3D4-27C8-4A3D-8CE4-2CA4EF7E4CEA Q47703147-5946CBF5-F6FD-4410-AEDA-F8A96EE00542 Q47740361-865650EB-062D-4D17-BC72-603383779EE9 Q48328230-BF3234E3-CB77-490E-A5EA-CAFC302730E9 Q48675205-31E6F945-41E3-409C-B7A8-63B02F75A817 Q49208785-13784870-B9F5-413C-852D-970228CA7763 Q49619782-F4BEC50F-EC7D-43FF-A442-82A2F9D923A8 Q50080940-ACB25CAB-9EAB-41FA-866D-2EBDD5764F16 Q50096902-7AD3D5E3-8BFD-4EFA-98C7-129D1B04129A Q50227686-58D318F0-3FD9-48EA-8A27-72A33A3A2050 Q50351390-96896DD1-1F86-4288-843A-7ED3286E8FDB Q52318759-DE81FCF0-40BE-4B56-89DF-01DA0B38E49E Q52638232-E24E1A19-A405-4919-827B-5BABDB1330F4 Q52671067-75BD5E50-219B-4691-9484-3190B139B2BC Q53702193-B0BE1AD4-840D-4A26-B9F6-D255E258F93E Q53707065-35BFE6A4-0773-4464-A0CE-CF13B3F13595 Q54983279-7E9FA8A3-15CF-4DB3-83D4-35CD018FCFB2 Q55054468-E22862AD-A905-417A-B9A5-A2DDE6C75B5A Q55148658-69C519ED-99CD-4009-A4F9-AD30E71F6E7C Q55314165-61750913-AF53-490D-81F4-03B82BA8C608 Q55380373-2CB9EBCF-0571-4447-BFB7-AEB46BDAAF7C Q56889140-1AF81052-7850-47B8-BC83-C86BCE06B637 Q57024703-AEEC142A-66C2-4002-96F1-A24A43E06E62 Q57170070-C168889D-8EB5-4D07-A4AE-F19379B0702D

P2860

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

http://www.wikidata.org/entity/Q39095733

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@en

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@nl

type

label

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@en

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@nl

prefLabel

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@en

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

@nl

P1433

Q39095733-7610D822-8413-4999-A2D9-0E91DD4F501D

P1476

Q39095733-59250C44-68A9-4019-8DC9-C2DBFFF5B5A1

P2093

Q39095733-0D77845F-F88E-48D0-A7FD-D9AADCFE0DB1

Q39095733-0E26AADF-253D-4677-BBDE-9125DEEF1E9D

Q39095733-2D7934D3-7974-4298-9A63-0692A7B75A5D

Q39095733-4BAE5298-0592-4E67-A0FE-FD5356085A93

Q39095733-560B896F-3A68-4BAF-8AAE-22B16123D9D0

Q39095733-5895E67B-84FB-4E73-96EE-6095153CEADD

Q39095733-5E80C7F6-A573-46C9-93E9-2023E6C1CE37

Q39095733-5EABAD80-2375-4E49-8EF0-3C2170769415

Q39095733-6C945C48-8B85-4B92-AD13-5AB249E5E802

Q39095733-7F75492A-E718-42A0-BA09-7B9318EE63C3

P2888

Q39095733-DC211CC5-E631-4D34-8B42-FFF34EB1E025

P304

Q39095733-068058AE-16F7-4DB9-9650-E9CA918910C2

P31

Q39095733-F3691ECF-F12F-44D7-9C3E-32046E45008A

P356

Q39095733-05D34224-8377-4540-90AA-BE62646EE0B9

P407

Q39095733-CEE4EF0C-1B86-4502-B896-2148CF44FC72

P433

Q39095733-D749E6A2-EC53-421F-9400-854687D82C56

P478

Q39095733-C16E11C6-B390-4927-A187-D271CE2F821F

P50

Q39095733-03571555-93E4-41C6-8F20-6CFB79FCA710

Q39095733-1A73F92F-FC5A-44C4-BA0C-29437790D3CD

Q39095733-1F53DC97-6B6E-484D-8096-7A487B0C15E6

Q39095733-22B818A1-5138-4D13-8F7B-2276C10A85A4

Q39095733-26EB6B56-881A-4F1E-869A-4B278B63C9CF

Q39095733-52E42095-2DDF-4B26-A5DC-01D3011649DE

Q39095733-542B4E08-9612-4B6F-8CF7-AA005FED6077

Q39095733-71480729-9AF9-4C54-B4BA-931353385EE5

Q39095733-72E3A17A-36CC-490C-80A5-EB4D16EA99EB

Q39095733-8FF2020E-302B-4E84-8E1E-50F3EEC7EC82

P577

Q39095733-9669F590-7811-4DB0-98F8-87866DDA65CA

P698

Q39095733-5E559F18-2B35-48B3-82D0-6AD0A9A8E2A0

P921

Q39095733-1C0BE74D-996C-4A8E-901A-AA0F007C9BE6

Q39095733-5257C3BA-9CB6-48A2-BDFF-5882EFBE7DBC

P356

P1433

Nature Reviews Cancer

P1476

Interrogating open issues in cancer precision medicine with patient-derived xenografts

@en

P2093

Alberto Villanueva

http://www.w3.org/2001/XMLSchema#string

Alejandra Bruna

http://www.w3.org/2001/XMLSchema#string

Alejandro Piris-Gimenez

http://www.w3.org/2001/XMLSchema#string

Andrea Bertotti

http://www.w3.org/2001/XMLSchema#string

Carlos Caldas

http://www.w3.org/2001/XMLSchema#string

Daniel S Peeper

http://www.w3.org/2001/XMLSchema#string

David K Chang

http://www.w3.org/2001/XMLSchema#string

Denis G Alférez

http://www.w3.org/2001/XMLSchema#string

Dominique Vanhecke

http://www.w3.org/2001/XMLSchema#string

Els Hermans

http://www.w3.org/2001/XMLSchema#string

P2888

P304

254-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRC.2016.140

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Héctor G. Palmer

Robert B. Clarke

Jean-Christophe Marine

Sergio Roman-Roman

Annette T. Byrne

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28104906

http://www.w3.org/2001/XMLSchema#string

P921